Wall Street is coming off a week that saw the Nasdaq Composite notch two consecutive records at its end. The S&P 500 , ...

Nasdaq stock has significantly outperformed the broader market over the past year, and analysts remain strongly bullish on ...

U.S. stock futures were fluctuating on Monday after following Friday's advances. Futures of major benchmark indices were ...

The One Nasdaq approach continued to accelerate cross-selling opportunities, with the company on track to surpass $100 million in run-rate revenue from cross-sells by the end of 2027. Cross-sells now ...

Palantir has its second-quarter earnings call scheduled on Aug. 4, after the market's closing bell. If it can maintain its ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a mini-rally that extended into Friday; the company's share price added nearly 5% ...

On Aug. 11, 2025, Dow, S&P 500, and Nasdaq futures edge higher as investors eye record highs and key inflation data this week ...

For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with ...

Two companies have recently seen their stock prices head higher on optimism about the future growth in AI spending. Palantir Technologies (NASDAQ: PLTR) shares are up 93% from their April low, as of ...

About This Event Axsome Therapeutics (Nasdaq: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, visits the Nasdaq MarketSite in Times ...

Palantir is taking the high ground in the artificial intelligence (AI) software revolution. The company has delivered nine consecutive quarters of accelerating revenue and profit growth thanks to its ...

Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Alphabet, ...